business
Hims & Hers stock sinks after quarterly loss, sales miss
Key takeaways
- Hims & Hers stock sinks after quarterly loss, sales miss Ines Ferré · Senior Business Reporter Tue, May 12, 2026 at 6:46 PM GMT+7 1 min read HIMS What happened: Hims & Hers Health (HIMS) stock sank 15% in premarket.
- What’s behind the move: The telehealth company reported a quarterly loss and sales that missed Wall Street expectations amid higher costs following the health platform s pivot to branded weight-loss medications.
- First quarter revenue of $608 million came in below the consensus estimates of $617.5 million.
Hims & Hers stock sinks after quarterly loss, sales miss Ines Ferré · Senior Business Reporter Tue, May 12, 2026 at 6:46 PM GMT+7 1 min read HIMS What happened: Hims & Hers Health (HIMS) stock sank 15% in premarket.
What’s behind the move: The telehealth company reported a quarterly loss and sales that missed Wall Street expectations amid higher costs following the health platform s pivot to branded weight-loss medications.
First quarter revenue of $608 million came in below the consensus estimates of $617.5 million. The company posted a loss per share of $0.40, compared with a profit of $0.20 last year.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop